Follow us on




Q of the week

Q: Do clinical trials ever go wrong?

Get the Answer: 

PAP TEST

A test to check for cancer of the cervix, the opening to a woman's womb. It is done by removing cells from the cervix. The cells are then prepared so they can be seen under a microscope.

 Forums
Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
The Wall Street Journal's special supplement on clinical trials   by  on 2010-05-01 01:31:52
Major developments in EU Clinical Trial Guidances   by  on 2010-04-20 19:10:55
Analysis of the adverse reactions induced by natural product-derived drugs   by  on 2010-04-18 23:16:06
Newer Antibacterial Drugs for a New Century   by  on 2010-04-18 22:49:47
Newer Non-Statin Drugs for Reducing Cholesterol   by  on 2010-04-13 07:57:20
Practice Guidelines for Chronic Pain Management   by  on 2010-04-04 20:52:16
CONSORT III (2010)   by  on 2010-03-29 12:53:28
US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function   by  on 2010-03-20 12:25:16
US-FDA issues First Draft Guidance on Noninferiority Trials   by  on 2010-03-04 14:07:46
US FDA new rule on reporting information regarding falsification of data   by  on 2010-02-25 20:47:33
US-FDA Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials   by  on 2010-02-06 12:12:14
 Subject :Ethical Guidelines for Intervention Studies in New Zealand.. 2009-11-30 10:28:34 
GCP HelpDesk
Moderator
Joined: 2009-06-18 15:31:58
Posts: 62
Location

NEAC has developed guidelines on conducting intervention studies that aim to contribute to better health outcomes for New Zealanders by further developing best practice in intervention studies.

In an intervention study, an investigator intervenes to prevent, diagnose or treat illness or disease, and also studies the effects of the intervention for its safety and/or benefit. A clinical trial of a new blood pressure medicine is an example of an intervention study.

The evidence that intervention studies provide is a fundamental driver of innovation, patient safety and improved care so healthcare organizations should welcome the conduct of well-designed intervention studies. Intervention studies also have the potential both to benefit and to harm participants, so it is important that they are scientifically and ethically sound.

These Guidelines aim to help investigators to think through and address the ethical issues in their studies. They bring together in one document, and build on, the best current national and international guidance on intervention studies. The Guidelines also aim to assist ethics committees, study sponsors, organisations that host research and others with an interest in intervention studies. They also address New Zealand-specific issues (eg, compensation for injury).

Document availability

Ethical Guidelines for Intervention Studies
If you would like a hard copy of this publication please email neac@moh.govt.nz

IP Logged
GCP HelpDesk
Page # 


Powered by ccBoard